974 related articles for article (PubMed ID: 7717560)
1. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Yee R
Anesthesiology; 1995 Apr; 82(4):888-95. PubMed ID: 7717560
[TBL] [Abstract][Full Text] [Related]
2. Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Sharpe MD; Cuillerier DJ; Lee JK; Basta M; Krahn AD; Klein GJ; Yee R
Anesthesiology; 1999 Jan; 90(1):60-5. PubMed ID: 9915313
[TBL] [Abstract][Full Text] [Related]
3. The electrophysiologic effects of volatile anesthetics and sufentanil on the normal atrioventricular conduction system and accessory pathways in Wolff-Parkinson-White syndrome.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Guiraudon G; Yee R
Anesthesiology; 1994 Jan; 80(1):63-70. PubMed ID: 8291732
[TBL] [Abstract][Full Text] [Related]
4. Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Guiraudon G; Yee R
Can J Anaesth; 1992 Oct; 39(8):816-21. PubMed ID: 1288908
[TBL] [Abstract][Full Text] [Related]
5. Effects of propofol or isoflurane anesthesia on cardiac conduction in children undergoing radiofrequency catheter ablation for tachydysrhythmias.
Lavoie J; Walsh EP; Burrows FA; Laussen P; Lulu JA; Hansen DD
Anesthesiology; 1995 Apr; 82(4):884-7. PubMed ID: 7717559
[TBL] [Abstract][Full Text] [Related]
6. [Electrophysiological effects of sevoflurane in comparison with propofol in children with Wolff-Parkinson-White syndrome].
Pérez ER; Bartolomé FB; Carretero PS; Fernández CS; Mateos EJ; Tarlovsky LG
Rev Esp Anestesiol Reanim; 2008 Jan; 55(1):26-31. PubMed ID: 18333383
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
[TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
9. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic characteristics, electropharmacologic responses and radiofrequency ablation in patients with decremental accessory pathway.
Chen SA; Tai CT; Chiang CE; Lee SH; Wen ZC; Chiou CW; Ueng KC; Chen YJ; Yu WC; Huang JL; Chang MS
J Am Coll Cardiol; 1996 Sep; 28(3):732-7. PubMed ID: 8772764
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of double ventricular response to a single atrial extrastimulus in patients with Wolff-Parkinson-White syndrome.
Matsuhisa M; Shimomura K; Ohe T; Kamakura S; Aihara N
Pacing Clin Electrophysiol; 1990 Apr; 13(4):443-52. PubMed ID: 1692128
[TBL] [Abstract][Full Text] [Related]
12. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Jiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
[TBL] [Abstract][Full Text] [Related]
13. Retrograde atrial preexcitation following premature ventricular beats during reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
Sellers TD; Gallagher JJ; Cope GD; Tonkin AM; Wallace AG
Eur J Cardiol; 1976 Sep; 4(3):283-94. PubMed ID: 964277
[TBL] [Abstract][Full Text] [Related]
14. Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome.
Klein GJ; Yee R; Sharma AD
Circulation; 1984 Sep; 70(3):402-11. PubMed ID: 6744543
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction.
Rinne C; Sharma AD; Klein GJ; Yee R; Szabo T
Am Heart J; 1988 May; 115(5):1042-7. PubMed ID: 3364337
[TBL] [Abstract][Full Text] [Related]
16. Effects of verapamil on accessory pathway properties and induction of circus movement tachycardia in patients with the Wolf-Parkinson-White syndrome.
Matsuyama E; Konishi T; Okazaki H; Matsuda H; Kawai C
J Cardiovasc Pharmacol; 1981; 3(1):11-24. PubMed ID: 6160340
[TBL] [Abstract][Full Text] [Related]
17. Wolff-Parkinson-White syndrome in children: electrophysiologic and pharmacologic characteristics.
Gillette PC; Garson A; Kugler JD
Circulation; 1979 Dec; 60(7):1487-95. PubMed ID: 498476
[TBL] [Abstract][Full Text] [Related]
18. High-dose remifentanil suppresses sinoatrial conduction and sinus node automaticity in pediatric patients under propofol-based anesthesia.
Fujii K; Iranami H; Nakamura Y; Hatano Y
Anesth Analg; 2011 May; 112(5):1169-73. PubMed ID: 21346159
[TBL] [Abstract][Full Text] [Related]
19. Cardiac electrophysiological effects of remifentanil: study in a closed-chest porcine model.
Zaballos M; Jimeno C; Almendral J; Atienza F; Patiño D; Valdes E; Navia J; Anadón MJ
Br J Anaesth; 2009 Aug; 103(2):191-8. PubMed ID: 19457895
[TBL] [Abstract][Full Text] [Related]
20. Conduction properties of accessory atrioventricular pathways: importance of the accessory pathway location and normal atrioventricular conduction.
Liu S; Yuan S; Olsson SB
Scand Cardiovasc J; 2003; 37(1):43-8. PubMed ID: 12745802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
